

Brookfield vs CME Group
Global asset manager focused on real estate and infrastructure vs Global futures and options exchange operator providing clearing services. Which is the better buy for your portfolio in November 2026? Plain-English answer below.
Brookfield Asset Management runs a global alternative investment platform managing hundreds of billions across infrastructure, real estate, credit, and private equity, growing fee-related earnings as successive flagship funds raise capital from institutions and wealth channels worldwide, while CME Group operates the world's largest derivatives exchange, generating nearly risk-free transaction fee income as traders hedge interest rates, commodities, energy, and equity indices around the clock. Both companies earn from deploying and intermediating vast pools of institutional capital through scaled platforms where network effects create durable barriers to competition. Brookfield vs CME Group explores how a capital-raising and long-duration asset deployment machine compares to a high-margin volume-driven exchange utility, letting readers assess fee durability, capital reinvestment requirements, and the different ways network effects compound into shareholder value.
Brookfield Asset Management runs a global alternative investment platform managing hundreds of billions across infrastructure, real estate, credit, and private equity, growing fee-related earnings as ...
Why It’s Moving

Brookfield Q3 Earnings Surge on AI Momentum and Insurance Growth
- Distributable earnings before realizations grew 14% year-over-year to $2.47 per share (TTM), while net income for the quarter reached $1.9 billion, supported by record fundraising that pushed fee-bearing capital to $682 billion.
- The Brookfield Wealth Solutions segment delivered a 22% year-over-year increase in distributable earnings, leveraging nearly $200 billion in insurance assets to deploy permanent float across its credit and operating platforms.
- Management highlighted emerging opportunities in AI infrastructure and confirmed progress in the sales process for German utility Uniper through a consortium with CPPIB, signaling continued expansion into critical energy assets.

CME Group Highlights Dominance in Derivatives and Prediction Markets Amid Analyst Downside Warnings
- CEO Terry Duffy discussed the integration of prediction markets alongside traditional financial instruments during a recent appearance on 'Power Lunch', highlighting new revenue avenues.
- Analysts note that CME maintains a dominant position in global derivatives with exceptionally high net margins, supported by a technology partnership with Alphabet.
- The company is cited for its wide economic moat and record trading volumes, which underpin disciplined capital allocation and strong cash returns to shareholders.

Brookfield Q3 Earnings Surge on AI Momentum and Insurance Growth
- Distributable earnings before realizations grew 14% year-over-year to $2.47 per share (TTM), while net income for the quarter reached $1.9 billion, supported by record fundraising that pushed fee-bearing capital to $682 billion.
- The Brookfield Wealth Solutions segment delivered a 22% year-over-year increase in distributable earnings, leveraging nearly $200 billion in insurance assets to deploy permanent float across its credit and operating platforms.
- Management highlighted emerging opportunities in AI infrastructure and confirmed progress in the sales process for German utility Uniper through a consortium with CPPIB, signaling continued expansion into critical energy assets.

CME Group Highlights Dominance in Derivatives and Prediction Markets Amid Analyst Downside Warnings
- CEO Terry Duffy discussed the integration of prediction markets alongside traditional financial instruments during a recent appearance on 'Power Lunch', highlighting new revenue avenues.
- Analysts note that CME maintains a dominant position in global derivatives with exceptionally high net margins, supported by a technology partnership with Alphabet.
- The company is cited for its wide economic moat and record trading volumes, which underpin disciplined capital allocation and strong cash returns to shareholders.
Investment Analysis
Pros
- Brookfield Corp benefits from diversified, long-duration real asset exposure across infrastructure, renewables, real estate, and private equity, providing resilience to economic cycles.
- The company’s global scale and presence in multiple high-growth geographies enable access to proprietary deal flow and sizeable investment opportunities not available to smaller competitors.
- Strong institutional partnerships and substantial third-party capital under management generate recurring, high-margin asset management fees and reduce dependence on balance sheet leverage.
Considerations
- Brookfield’s elevated leverage and debt-to-equity ratio increase sensitivity to rising interest rates and refinancing risks in volatile credit markets.
- Complex corporate structure and multiple subsidiaries create challenges in transparency, governance, and consistent investor communication.
- Exposure to illiquid, long-term real assets may result in valuation volatility and limited flexibility during periods of market stress or liquidity contraction.

CME Group
CME
Pros
- CME Group operates the world’s largest and most liquid derivatives marketplace, with a near-monopoly position in key global benchmark products for interest rates, equity indices, commodities, and FX.
- The business model is highly scalable and cash-generative, driven by high-margin electronic trading, recurring clearing revenues, and minimal operational leverage in a largely fixed-cost infrastructure.
- Global regulatory emphasis on central clearing and risk management supports long-term structural growth in demand for CME’s core products and services.
Considerations
- CME Group’s earnings are sensitive to trading volumes, which can fluctuate significantly with macro volatility, interest rate cycles, and investor risk appetite.
- The company faces increasing competition from alternative trading venues, regional exchanges, and over-the-counter markets, which may erode pricing power over time.
- Regulatory changes or shifts in clearing mandates could disrupt business flows, while market structure reforms may reduce the profitability of certain legacy products.
Brookfield (BN) Next Earnings Date
No confirmed upcoming earnings date has been announced for BN as of November 16, 2026. Based on the historical reporting pattern where the company typically releases results approximately three months after the previous quarter's close, the next report is expected in February 2027. This anticipated release will cover the fourth quarter and full fiscal year 2026 results. Investors should monitor official channels for the specific date confirmation closer to that period.
CME Group (CME) Next Earnings Date
CME Group has not yet announced a confirmed date for its next earnings release. Based on the company's historical reporting pattern, which typically follows a three-month cycle after the previous quarter's close, the upcoming report is expected in February 2027. This scheduled update will cover financial results for the fourth quarter of fiscal year 2026. Investors should monitor official corporate communications for the precise announcement timing.
Brookfield (BN) Next Earnings Date
No confirmed upcoming earnings date has been announced for BN as of November 16, 2026. Based on the historical reporting pattern where the company typically releases results approximately three months after the previous quarter's close, the next report is expected in February 2027. This anticipated release will cover the fourth quarter and full fiscal year 2026 results. Investors should monitor official channels for the specific date confirmation closer to that period.
CME Group (CME) Next Earnings Date
CME Group has not yet announced a confirmed date for its next earnings release. Based on the company's historical reporting pattern, which typically follows a three-month cycle after the previous quarter's close, the upcoming report is expected in February 2027. This scheduled update will cover financial results for the fourth quarter of fiscal year 2026. Investors should monitor official corporate communications for the precise announcement timing.
Buy BN or CME in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.


